- info@researchchemics.com |
- 470-659-0886
MT-45 [1-cyclohexyl-4-(1,2-diphenylethyl)piperazine], also known as IC-6, NSC 299236 and CDEP, is a synthetic opioid developed as a therapeutic drug candidate in the 1970s by the Dainippon Pharmaceutical Co. in Japan. MT-45 has never been commercially available as a therapeutic agent; however, it has appeared on the illicit recreational drug market in recent years, but not extensively.
$500.00 – $950.00
MT-45 (IC-6) is an opioid analgesic drug . It is chemically a 1-substituted-4-(1,2-diphenylethyl)piperazine derivative, which is structurally unrelated to most other opioid drugs. Racemic MT-45 has around 80% the potency of morphine, with almost all opioid activity residing in the (S) enantiomer (the opposite stereochemistry from the related drug lefetamine). It has been used as a lead compound from which a large family of potent opioid drugshave been developed, including full agonists, partial agonists, and antagonists at the three main opioid receptor subtypes.Fluorinated derivatives of MT-45 such as 2F-MT-45 are significantly more potent as μ-opioid receptor agonists, and one of its main metabolites 1,2-diphenylethylpiperazine also blocks NMDA receptors.Buy MT-45 Powder online
These drugs pose a higher risk of causing habit forming behaviour, take particular care with the amount and frequency they are taken.
Depressants are drugs which reduce arousal and stimulation in the user, characterised by a depressing of mental and physical functions.
Opioids are pain-killing depressants which may also cause euphoria.
| Weight | 50g, 100g |
|---|
Only logged in customers who have purchased this product may leave a review.
Research Chemics is one of the largest suppliers of Research Chemicals in America and Europe. We are firmly established as a go-to source for a wide range of RC’s, providing well-researched.
Copyright 2023 © Researchchemics.com
Reviews
There are no reviews yet.